Fertility and sterility · 2007
Sexual function in young women with spontaneous 46,XX primary ovarian insufficiency.
СтатьяРандомизированное исследованиеResearch Support, N.I.H., IntramuralНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kalantaridou Sophia N, Vanderhoof Vien H, Calis Karim A, Corrigan Emily C, Troendle James F, Nelson Lawrence M
Аннотация
OBJECTIVE: To assess sexual function in women with spontaneous 46,XX primary ovarian insufficiency after at least 3 months of a standardized hormone replacement regimen.
DESIGN: Cross-sectional cohort, controlled.
SETTING: National Institutes of Health Clinical Research Center.
PATIENT(S): Women with primary ovarian insufficiency (n = 143) and regularly menstruating controls (n = 70).
INTERVENTION(S): Self-administered questionnaires, 100 microg/day E(2) patch, oral medroxyprogesterone acetate 10 mg for 12 days each month for patients.
MAIN OUTCOME MEASURE(S): Derogatis Interview for Sexual Function Self-Report (DISF-SR).
RESULT(S): Women with primary ovarian insufficiency had significantly lower DISF-SR composite scores compared with control women. Their serum total testosterone levels were significantly correlated with DISF-SR composite score, although this accounted for only 4% of the variance in this measure. Patients with testosterone levels below normal tended to have lower DISF-SR composite scores. Of patients with primary ovarian insufficiency, 9 of 127 (7%) scored below the second percentile on the composite sexual function score, compared with 1 of 49 control women (2%).
CONCLUSION(S): As assessed by the DISF-SR, sexual function is in the normal range for most young women with 46,XX spontaneous primary ovarian insufficiency who are receiving physiologic E(2) replacement. However, as a group, these young women score significantly lower on this sexual function scale than control women.
DESIGN: Cross-sectional cohort, controlled.
SETTING: National Institutes of Health Clinical Research Center.
PATIENT(S): Women with primary ovarian insufficiency (n = 143) and regularly menstruating controls (n = 70).
INTERVENTION(S): Self-administered questionnaires, 100 microg/day E(2) patch, oral medroxyprogesterone acetate 10 mg for 12 days each month for patients.
MAIN OUTCOME MEASURE(S): Derogatis Interview for Sexual Function Self-Report (DISF-SR).
RESULT(S): Women with primary ovarian insufficiency had significantly lower DISF-SR composite scores compared with control women. Their serum total testosterone levels were significantly correlated with DISF-SR composite score, although this accounted for only 4% of the variance in this measure. Patients with testosterone levels below normal tended to have lower DISF-SR composite scores. Of patients with primary ovarian insufficiency, 9 of 127 (7%) scored below the second percentile on the composite sexual function score, compared with 1 of 49 control women (2%).
CONCLUSION(S): As assessed by the DISF-SR, sexual function is in the normal range for most young women with 46,XX spontaneous primary ovarian insufficiency who are receiving physiologic E(2) replacement. However, as a group, these young women score significantly lower on this sexual function scale than control women.
Предметные рубрики MeSH
Administration, CutaneousAdministration, OralAdultCross-Sectional StudiesDouble-Blind MethodEstrogen Replacement TherapyEstrogensFemaleGonadal Dysgenesis, 46,XXHumansMedroxyprogesterone AcetatePrimary Ovarian InsufficiencyProspective StudiesSexual BehaviorSexual Dysfunction, PhysiologicalSurveys and QuestionnairesTestosteroneTreatment OutcomeYoung Adult